Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
Historia
27
Filosofía
14
Libre albedrío y determinismo
10
Jazz
9
Música popular
9
Aspectos económicos
8
Sociología
8
Etnología
7
Comercio
6
Aspectos psicológicos
5
Aspectos sociales
5
Cambio social
5
Ciudades y pueblos
5
Libre comercio
5
Modelos matemáticos
5
Política económica
5
Política gubernamental
5
Abuso de drogas
4
Administración
4
Ciencias sociales
4
Condiciones sociales
4
Democracia
4
Educación
4
Filosofía de la mente
4
History
4
Inglés
4
Mercadotecnia
4
Política y gobierno
4
Sistemas operativos (Computadoras)
4
Urbanismo
4
-
485161“…The study measured objective remission rate (ORR), 3-year progression-free survival (PFS) rate, 3-year overall survival (OS) rate, recurrence rate, and side effects as endpoints. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485162por Binyu, Luo, Qin, Zhang, Xiao, Zhang, Daquan, Zhang, Qing, Guo, Jing, Yu, Yunhong, Tian, Mingyang, Ren“…The patients in both groups underwent laparoscopic tension-free repair of their inguinal hernias. General information such as operative time, postoperative hospital stay, and hospital cost were compared between the two groups, and the patients were followed up at 1, 7, 14, 21, and 28 days and then 3, 6, and 12 months after surgery to compare complications such as incidence of seroma, volume of the seroma fluid, incidence of pain, and visual analogue scale (VAS) pain score. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485163por Yang, Kun, Zhang, Weihan, Chen, Zehua, Chen, Xiaolong, Liu, Kai, Zhao, Linyong, Hu, Jiankun“…There were no statistically significant differences in 5-year overall survival (79% [55/70] of the B-I group vs. 80% [56/70] of the R-Y group, P = 0.966) and recurrence-free survival rates (79% [55/70] of the B-I group vs. 78% [55/70] of the R-Y group, P = 0.979) between the two groups. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485164por Zadnik, Karla, Schulman, Erica, Flitcroft, Ian, Fogt, Jennifer S., Blumenfeld, Louis C., Fong, Tung M., Lang, Eric, Hemmati, Houman D., Chandler, Simon P.“…OBJECTIVE: To assess the safety and efficacy of NVK002 (Vyluma), a novel, preservative-free, 0.01% and 0.02% low-dose atropine formulation for treating myopia progression. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485165por Viardot-Foucault, Veronique, Zhou, Jieliang, Bi, Dexi, Takinami, Yoshihiko, Chan, Jerry. K. Y., Lee, Yie Hou“…In DHEA- patients, valine negatively correlated with serum-free testosterone (Pearson r: -0.8774; p < 0.0001). …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485166por Thongsom, Sunisa, Racha, Satapat, Petsri, Korrakod, Ei, Zin Zin, Visuttijai, Kittichate, Moriue, Sohsuke, Yokoya, Masashi, Chanvorachote, Pithi“…MD simulations revealed that the binding between MOS and Akt1 was more stable than RES, with MM/GBSA binding free energy of − 32.8245 kcal/mol at its allosteric site. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485167por Geurts, Sven, Tilly, Martijn J., Arshi, Banafsheh, Stricker, Bruno H. C., Kors, Jan A., Deckers, Jaap W., de Groot, Natasja M. S., Ikram, M. Arfan, Kavousi, Maryam“…METHODS: 12,334 participants free of AF from the population-based Rotterdam Study were included. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485168“…In Group III, the swine spontaneously breathed, but the axillary hemorrhage was controlled using vascular blocking bands without SJT compression. The amount of free blood loss was calculated in the axillary wound during the 2 h of hemostasis by SJT application or vascular blocking bands. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485169por Damayanti, Nur P., Saadatzadeh, M. Reza, Dobrota, Erika, Ordaz, Josue D., Bailey, Barbara J., Pandya, Pankita H., Bijangi-Vishehsaraei, Khadijeh, Shannon, Harlan E., Alfonso, Anthony, Coy, Kathy, Trowbridge, Melissa, Sinn, Anthony L., Zhang, Zhong-Yin, Gallagher, Rosa I., Wulfkuhle, Julia, Petricoin, Emanuel, Richardson, Angela M., Marshall, Mark S., Lion, Alex, Ferguson, Michael J., Balsara, Karl E., Pollok, Karen E.“…Pleomorphic xanthoastrocytoma (PXA) is a rare subset of primary pediatric glioma with 70% 5-year disease free survival. However, up to 20% of cases present with local recurrence and malignant transformation into more aggressive type anaplastic PXA (AXPA) or glioblastoma. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485170por Gan, Ziming, Zhou, Doudou, Rush, Everett, Panickan, Vidul A., Ho, Yuk-Lam, Ostrouchov, George, Xu, Zhiwei, Shen, Shuting, Xiong, Xin, Greco, Kimberly F., Hong, Chuan, Bonzel, Clara-Lea, Wen, Jun, Costa, Lauren, Cai, Tianrun, Begoli, Edmon, Xia, Zongqi, Gaziano, J. Michael, Liao, Katherine P., Cho, Kelly, Cai, Tianxi, Lu, Junwei“…OBJECTIVE: Electronic health record (EHR) systems contain a wealth of clinical data stored as both codified data and free-text narrative notes, covering hundreds of thousands of clinical concepts available for research and clinical care. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485171por Kim, Mi-Jeong, Kim, Ji Young, Shin, Ji Hye, Kang, Yeeun, Lee, Ji Su, Son, Juhee, Jeong, Soo-Kyung, Kim, Daesik, Kim, Duk-Hwan, Chun, Eunyoung, Lee, Ki-Young“…BACKGROUND: Free fatty acid receptors (FFARs) and toll-like receptors (TLRs) recognize microbial metabolites and conserved microbial products, respectively, and are functionally implicated in inflammation and cancer. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485172por Bailén, Rebeca, Alenda, Raquel, Herruzo-Delgado, Beatriz, Acosta-Fleitas, Cynthia, Vallés, Ana, Esquirol, Albert, Fonseca, Marta, Solán, Laura, Sánchez-Vadillo, Irene, Bautista, Guiomar, Bento, Leyre, López-Godino, Oriana, Pérez-Martínez, Ariadna, Torrent, Anna, Zanabili, Joud, Calbacho, María, Moreno, Miguel Ángel, Pascual-Cascón, María Jesús, Guerra-Domínguez, Luisa, Chinea, Anabelle, García-Cadenas, Irene, López-Corral, Lucía, Boix-Giner, Francisco, López Lorenzo, José Luis, Humala, Karem, Duarte, Rafael, Sampol, Antonia, Heras, Inmaculada, Vicario, José Luis, Balas, Antonio, Oarbeascoa, Gillen, Fernández-Caldas, Paula, Anguita, Javier, Kwon, Mi“…After a median follow-up of 30 months, two-year overall and event-free survival were 46.5% and 39%, respectively. The two-year cumulative incidence of relapse was 16% and non-relapse mortality (NRM) was 43%. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485173por Nussbaumer, Gunther, Benesch, Martin, Grabovska, Yura, Mackay, Alan, Castel, David, Grill, Jacques, Alonso Roldán, Marta M, Antonelli, Manila, Bailey, Simon, Baugh, Joshua N, Broniscer, Alberto, Crampsie, Shauna, Entz-Werle, Natacha, Eyrich, Matthias, Garre, Maria L, Gerber, Nicolas U, Giangaspero, Felice, Gil-da-Costa, Maria J, Hargrave, Darren, Hauser, Peter, Herrlinger, Ulrich, Hoffmann, Marion, Jacobs, Sandra, Karremann, Michael, Kattamis, Antonis, Kebudi, Rejin, Kwiecien, Robert, Massimino, Maura, Mastronuzzi, Angela, Pentikainen, Virve, Perwein, Thomas, Pfister, Stefan M, Pietsch, Torsten, Sturm, Dominik, Sumerauer, David, van Vuurden, Dannis, von Bueren, André O, Varlet, Pascale, van Zanten, Sophie E M Veldhuijzen, Vinci, Maria, Warmuth-Metz, Monika, Wesseling, Pieter, Wiese, Maria, Zamecnik, Josef, La Madrid, Andrés Morales, Bison, Brigitte, Gielen, Gerrit H, Jones, David T W, Jones, Chris, Kramm, Christof M“…Within a median follow-up of 15.5 months (range, 2.3–138.8), 93 patients (89.4%) had died, four (3.8%) were lost to follow-up and seven (6.8%) were alive with stable/progressive disease. Median progression-free- (PFS) and overall survival (OS) were 8.6 months (interquartile range, 4.3–14.0) and 15.5 months (10.9–27.7), respectively. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485174por Wang, Yuan, Qin, Wan-yun, Wang, Qi, Liu, Xin-na, Li, Xiang-hui, Ye, Xin-qi, Bai, Ying, Zhang, Yan, Liu, Pan, Wang, Xin-lin, Zhou, Yu-hang, Yuan, Hui-ping, Shao, Zheng-bo“…CONCLUSION: This study elucidates a potential new therapeutic approach for neuroprotection against I/R injury, via delivering miR-150-5p-enriched Sca-1(+) exosomes, which targets the miR-150-5p/MEKK3/JNK/c-Jun axis, thereby serving as a cell-free remedy for treating retinal I/R injury and preserving visual functioning. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485175por Zhu, Hong-Fei, Feng, Jin-Kai, Xiang, Yan-Jun, Wang, Kang, Zhou, Li-Ping, Liu, Zong-Han, Cheng, Yu-Qiang, Shi, Jie, Guo, Wei-Xing, Cheng, Shu-Qun“…The clinical utility of this score to predict progression-free survival (PFS) and differentiate objective response rate (ORR) and disease control rate (DCR) was also performed. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485176“…Using the multivariate Cox model, the Eastern Cooperative Oncology Group (ECOG) score status (hazard ratio [HR]: 4.818, 95% confidence intervals [CI]: 2.076–11.184, p < 0.001) and eosinophil count (HR: 0.276, 95% CI: 0.120–0.636, p = 0.003) were independent prognostic factors of progression-free survival (PFS) in patients with ESCC. Metastatic sites (HR: 2.092, 95% CI: 1.307–3.351, p = 0.002) and eosinophil-to-lymphocyte ratio (ELR; HR: 0.379, 95% CI: 0.161–0.893, p = 0.027) were independent prognostic factors for overall survival (OS) in patients with ESCC. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485177por Afolabi, Olakunle Bamikole, Olasehinde, Oluwaseun Ruth, Olanipon, Damilola Grace, Mabayoje, Samson Olatunde, Familua, Olufemi Michael, Jaiyesimi, Kikelomo Folake, Agboola, Esther Kemi, Idowu, Tolulope Olajumoke, Obafemi, Olabisi Tajudeen, Olaoye, Oyindamola Adeniyi, Oloyede, Omotade Ibidun“…RESULTS: HPLC technique identified twelve chemical compounds in PEHc, while antioxidant quantification revealed higher total phenolic contents (243.5 ± 0.71 mg GAE/g) than total flavonoid contents (54.06 ± 0.09 mg QE/g) with a significant (p < 0.05) inhibition of ABTS (IC(50) = 218.30 ± 0.87 µg/ml) and 1, 1-diphenyl-2-picrylhydrazyl free radicals (IC(50) = 227.79 ± 0.74 µg/ml). In a similar manner, the extract demonstrated a significant (p < 0.05) inhibitory activity against α-amylase (IC(50) = 256.88 ± 6.15 µg/ml) and α-glucosidase (IC(50) = 183.19 ± 0.23 µg/ml) as well as acetylcholinesterase (IC(50) = 262.95 ± 1.47 µg/ml) and butyrylcholinesterase (IC(50) = 189.97 ± 0.82 µg/ml), respectively. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485178por Wu, Hanzhang, Gu, Yeqing, Meng, Ge, Zhang, Qing, Liu, Li, Wu, Hongmei, Zhang, Shunming, Zhang, Tingjing, Wang, Xuena, Zhang, Juanjuan, Sun, Shaomei, Wang, Xing, Zhou, Ming, Jia, Qiyu, Song, Kun, Chang, Hong, Huang, Tao, Niu, Kaijun“…All participants were free of a history of cardiovascular disease (CVD), cancer, and depressive symptoms at baseline. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485179por Chen, Weiming, Ao, Yang, Lan, Xiaochun, Tong, Wenzhou, Liu, Xiaohui, Zhang, Xia, Ye, Qiang, Li, Yin, Liu, Linfen, Ye, Hao, Zhuang, Pan, Zhang, Yu, Zheng, Weifang, Jiao, Jingjing“…METHODS: Eight thousand seven hundred forty-two subjects free of overweight/obesity at entry in the China Health and Nutrition Survey (CHNS) were followed up until 2015. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
485180por Jin, Hyun, Jin, Myung, Lim, Chae Hong, Choi, Joon Young, Kim, Seok-Jin, Lee, Kyung-Han“…Kaplan–Meier survival analysis and the Cox proportional hazards model assessed the ability to predict overall survival (OS) and progression-free survival (PFS). RESULTS: During a median follow-up period of 5.4 years (maximum of 12.7 years), events occurred in 85 patients, including progression, relapse, and death (65 deaths occurred at a median of 17.6 months). …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto